University of Colorado Hospital - Anschutz Inpatient Pavilion (AIP) — Aurora, Colorado

Public research footprint of University of Colorado Hospital - Anschutz Inpatient Pavilion (AIP), compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

ALK-positive Non Small Cell Lung Cancer (NSCLC) and ROS1-positive… · Carcinoma, Non-Small-Cell Lung · HR+ HER2- Metastatic Breast Cancer, Ovarian Cancer, Fallopian Tube… · Squamous Cell Carcinoma of the Head and Neck

Recently updated registry entries

NCT05355701 — A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced… (Recruiting)
NCT03975647 — A Study of Tucatinib vs. Placebo in Combination With Ado-trastuzumab Emtansine (T-DM1)… (Active Not Recruiting)
NCT06447662 — A Study to Learn About the Study Medicine PF-07934040 When Given Alone or With Other… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at University of Colorado Hospital - Anschutz Inpatient Pavilion (AIP)?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.